about us

Our mission is to be the first to market publicly traded Canadian pharmaceutical Psilocybin Company specializing in R&D and Clinical Trials to help patients with PTSD, depression, drug addictions and mental health disorders in first responders and Veterans through Health Canada licensing with Good Manufacturing Practices (GMP) and ISO 9001 standards.

The brand FIVE Pharmaceuticals represents our focus to the FIVE key controlled substances Ketamine, Psilocybin, MDMA, DMT and Mescaline under our FIVE corporate branches Sciences, Pharmaceuticals, Labs, Research and Clinical Trials.

website coming soon

contact us

learn about us in our comprehensive deck

download